GenHealth.ai vs Trase
Two RCM Automation Platforms vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| GenHealth.ai | Trase | |
|---|---|---|
| Pricing model | Usage-based · Per workflow, plus actions run each month | Enterprise contract (custom) · No upfront fee, billed on efficiency gains |
| Speed to go live | Browser agents, no EHR integration project | Prebuilt agent library deploys in weeks |
| Automation model | Autonomous agents · AI agents execute RCM workflows | Autonomous agents · Governed agent OS for regulated work |
| Built for | Small practices, Mid-size groups, Payers | Enterprise systems |
| Security posture | SOC 2 Type II, HIPAA | SOC 2 Type I, HIPAA |
| Company maturity | 3 yrs (est. 2023) | Not disclosed |
| Financial backing | $13M · Seed | $117.5M ($10.5M pre-seed plus $107M seed) · Seed |
| Named customers | 5 named | 2 named |
| Published results | Specific numbers public | Specific numbers public |
| Documented integrations | EHR-agnostic | None documented |
| Third-party validation | KLAS / analyst cited | None found |
Bottom line
- Pick GenHealth.ai if you want prior auth, eligibility, claims automation, or other custom work done by autonomous agents in your existing systems within weeks, without an integration project.
- Pick Trase if you are an academic or large health system that wants governed AI agents across back-office workflows and prefers paying from measured efficiency gains.
GenHealth.ai
An agentic OS for healthcare administration
- Founded
- 2023
- HQ
- San Francisco, CA
- Stage
- Seed
- Raised
- $13M
What it does
- Reads faxed and emailed orders and enters intake data into the EMR
- Verifies eligibility and benefits before orders move forward
- Drafts and submits prior authorizations matched to payer policy
- Checks clinical documentation against payer criteria and flags gaps
- Files claims and works denials and collections
- Automates resupply programs and utilization management review
Where it's strong
- Publishes customer results with real numbers: Piedmont Medical Solutions reported a 34.2% increase in paid-to-date collections, and Guidehealth reported $1.2M in annual savings.
- Multimodal by design: direct integrations with Epic, eClinicalWorks, athenahealth, and Brightree, plus browser agents that log in and work any portal, fax queue, or phone tree without an API.
- Founded by the team behind interoperability company 1upHealth, with backing from Craft Ventures and Obvious Ventures and advisors including Aneesh Chopra and Don Rucker.
- Named in multiple Gartner Hype Cycle reports, including Healthcare Data, Analytics and AI (2024), Generative AI (2024), and US Healthcare Payers (2025), rare analyst visibility for a seed-stage company.
What buyers should weigh
- Founded in 2023 and still at seed stage, so it is a young vendor compared with established RCM and prior auth incumbents.
- Public case studies concentrate in DME/HME and MSO utilization management; evidence in other care settings is thinner.
- No new funding round has been publicly announced since the July 2023 seed, so buyers should ask about company scale and support capacity.
Named customers
Piedmont Medical Solutions · Guidehealth · MedExpress · Soundview Medical · Spectrum Medical
Integrations
Trase
Governed AI agents for healthcare back-office work
- Founded
- n/a
- HQ
- McLean, VA
- Stage
- Seed
- Raised
- $117.5M ($10.5M pre-seed plus $107M seed)
What it does
- AI agents for inbound fax triage and routing
- Patient access workflow automation
- Revenue cycle task automation
- HIPAA and SOC 2 compliant agent platform
- Governance and oversight controls for agent actions
Where it's strong
- Live health system deployment at Duke, where fax triage ran 7.1 times faster than manual processing and saved about 1,395 staff hours a month.
- The $107M seed led by ARCH Venture Partners gives it unusual capital depth for a company at this stage.
- Pricing tied to measured efficiency gains lowers the risk of paying for software that does not perform.
What buyers should weigh
- The company only came out of stealth in November 2025, so the reference base beyond Duke Health is thin.
- The platform spans healthcare, defense, and other regulated industries, so healthcare-specific product depth may lag single-focus rivals.
- Published results center on fax triage; patient access and RCM claims have less public evidence.
Named customers
Duke Health · U.S. Navy
Compare against the rest of RCM Automation Platforms
Deciding between these two?
First Pass tracks RCM Automation Platforms every week: funding, launches, and what changed since this page was written.